Muni Y. Hu

145 Middle Shandong Road
Shanghai, 200001, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Cross-kingdom metabolic interactions govern Candida albicans overgrowth and colitis progression.

Cross-kingdom metabolic interactions govern Candida albicans overgrowth and colitis progression.

Journal: Cell host & microbe

Published: October 09, 2025

Microbial phosphoketolase promotes histone lactylation to improve anti-TNF therapy efficacy in inflammatory bowel disease.

Microbial phosphoketolase promotes histone lactylation to improve anti-TNF therapy efficacy in inflammatory bowel disease.

Journal: Cell metabolism

Published: September 21, 2025

Gut pathogen Clostridium symbiosum rewires macrophage succinylation to drive enteric neuron loss in inflammatory bowel disease.

Gut pathogen Clostridium symbiosum rewires macrophage succinylation to drive enteric neuron loss in inflammatory bowel disease.

Journal: Cell host & microbe

Published: September 03, 2025

Microbiota Transplantation in Tumor Immunology Studies.

Microbiota Transplantation in Tumor Immunology Studies.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: May 22, 2025

Bacteroides fragilis Toxin Suppresses METTL3-Mediated m6A Modification in Macrophage to Promote Inflammatory Bowel Disease.

Bacteroides fragilis Toxin Suppresses METTL3-Mediated m6A Modification in Macrophage to Promote Inflammatory Bowel Disease.

Journal: Journal of Crohn's & colitis

Published: March 11, 2025

Optimizing anti-PD-1/PD-L1 therapy efficacy and fecal microbiota transplantation donor selection through gut mycobiome-based enterotype.

Optimizing anti-PD-1/PD-L1 therapy efficacy and fecal microbiota transplantation donor selection through gut mycobiome-based enterotype.

Journal: Cell reports

Published: August 01, 2024

Synergistic role of gut-microbial L-ornithine in enhancing ustekinumab efficacy for Crohn's disease.

Synergistic role of gut-microbial L-ornithine in enhancing ustekinumab efficacy for Crohn's disease.

Journal: Cell metabolism

Published: July 30, 2024

Microbial metabolite FAD mobilizes adipocyte lipid remodeling to enhance cancer immunotherapy efficacy.

Microbial metabolite FAD mobilizes adipocyte lipid remodeling to enhance cancer immunotherapy efficacy.

Journal: Cell metabolism

Published: July 02, 2024

Microbial and Transcriptomic Landscape Associated With Neutrophil Extracellular Traps in Perianal Fistulizing Crohn's Disease.

Microbial and Transcriptomic Landscape Associated With Neutrophil Extracellular Traps in Perianal Fistulizing Crohn's Disease.

Journal: Inflammatory bowel diseases

Published: May 09, 2024

Interplay between gut microbial communities and metabolites modulates pan-cancer immunotherapy responses.

Interplay between gut microbial communities and metabolites modulates pan-cancer immunotherapy responses.

Journal: Cell metabolism

Published: April 14, 2024

A specific enterotype derived from gut microbiome of older individuals enables favorable responses to immune checkpoint blockade therapy.

A specific enterotype derived from gut microbiome of older individuals enables favorable responses to immune checkpoint blockade therapy.

Journal: Cell host & microbe

Published: September 28, 2023

Microbiome and metabolome features in inflammatory bowel disease via multi-omics integration analyses across cohorts.

Microbiome and metabolome features in inflammatory bowel disease via multi-omics integration analyses across cohorts.

Journal: Nature communications

Published: May 24, 2023

Showing 1-12 of 20

Last Updated: 09/26/2026